Can Bill Gates Cure Cancer?

By Travis Johnson, Stock Gumshoe, March 13, 2008

Just a quick note to update you on a teaser that I wrote about a little while ago … it’s being repeated again.

This time, the email is going out from a different part of the Lynn Carpenter empire, as part of the Total Health Breakthroughs email newsletter … and they’d still like you to sign up for the Rising Tide Letter (still $99 a year).

But now they’re selling it based not specifically on the Baker Brothers, but on something else … here’s the snippet:

“These famous — and married — philanthropists are the two most giving people you might ever meet. Their sole purpose is to invest in revolutionary advancements that could easily enhance someone’s life… sometimes even extending it …. So when I saw that they bought five percent of a small biotech company, I had to see what it was all about.”

Those famous, married philanthropists are indeed quite giving, especially if you measure the extent of their giving-ness by the amount they’ve given. They are, of course, Bill and Melinda Gates … and their foundation, which does a fair amount of healthcare investing both to make money and to support worthy causes, has indeed picked up about 5% of this company.

And the company remains, as those who saw the original writeup I did will no doubt remember, Seattle Genetics (SGEN).

You can check out the first article I put up about this “Baby Biotech Blue-Chip” here if you’re interested. My opinion on this one hasn’t changed (the shares have moved up a bit, perhaps thanks to the attention brought by this recommendation) … but perhaps yours has.

Feel free to share, and happy investing to all.

Are you getting our free Daily Update
"reveal" emails? If not,
just click here...



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
Woman with Portfolio
March 13, 2008 5:07 pm

There is a very similar situation with a stock that looks remarkably similar in its ticker: ZGEN vs. SGEN. I’m surprised ZGEN hasn’t been hyped. I first noticed ZymoGenetics, also located in Seattle, as it happens, from a pattern of very heavy insider buying, as well as increasingly hefty buys from Warburg Pincus. For those watching SGEN, they should add ZGEN as well.

ZymoGenetics makes thrombin, theprotein used by surgeons to stop minor bleeding during surgery. Of the three thrombin products on the market, ZymoGenetics’ Recothrom is the only protein in the recombinant form, which means it isn’t derived from animal or human blood and is thus viewed as safer than its counterparts. The companies that make animal-derived thrombin are fighting hard, Omrix and King, but in previous situations like this, the recombinant ultimately wins out. Who wants cow-blood protein, given all the mad cow scares?

Anyhow, worth a look.

Add a Topic
Add a Topic
March 13, 2008 6:35 pm

Maybe there are data somewhere that give a different perspective, but a quick look at Yahoo Finance shows that recent institutional selling of ZGEN was about five times the level of recent insider buying.